Pfizer has been developing treatments to target weight loss in diabetes and obesity patients, as it races to target a market estimated to reach $100 billion by the end the of decade
Diabetes occurs when the body loses the ability to control blood sugar, and it's one of the world's most common serious diseases
Business Standard brings you the top headlines at this hour
A loss of the body's ability to control blood sugar levels, diabetes affects one in 10 adults globally and caused 6.7 million deaths in 2021, the International Diabetes Federation estimates
Type 1 diabetes is seen most often in children and young adults, although the disease can occur at any age, but it is less common than type 2 diabetes
The study involved 1,126 overweight and obese people who were randomly assigned to receive either metformin or a placebo within three days of testing positive for Covid-19
The prevalence of diabetes in India is 11.4 per cent, while 35.5 per cent of people suffer from hypertension, according to the findings of a nationwide survey published in Lancet journal
Union minister Jitendra Singh on Sunday said India is fast becoming a huge medical tourism hub and it is ready to lead technology-driven diabetes care
The study aimed to determine whether there was a link between childhood adversity and the development of T2D in early adulthood (16-38 years) among men and women
The findings, published in JAMA Network Open, showed that men were more likely to develop diabetes than women
Poor diet contributed to over 14.1 million cases of type 2 2 diabetes in 2018, representing over 70 per cent of new diagnoses globally, according to a study
Union Minister Jitendra Singh Friday made a strong pitch for the prevention of diabetes in pregnancy to prevent the passing of the health condition to future generations
If perfected, such a breakthrough would be a boon to diabetics and help cement Apple as a powerhouse in health care
This research, Kwan says, is one piece of the puzzle that will help researchers understand how to prevent metabolic as well as cardiovascular disease risk in the future
Drug firm Glenmark said it has received approval from the US health regulator to market a generic medication to treat diabetes in the American market.
Omicron has been seen as a milder version of Covid compared with earlier strains, leading to lower rates of hospitalization and death than delta and the strain that first emerged from China
Multiple levers are available to improve public health
It is priced at Rs 14.90 per day, thereby reducing the daily cost of therapy by 40 per cent, making it more affordable to the masses, the company said in a statement
Torrent Pharmaceuticals on Wednesday said it has inked a pact with Boehringer Ingelheim India to co-market diabetes drug and its combinations in the country